- Pharmaceuticals: Interactive cost-utility Markov-Microsimulation model (MCMC) with Excel®, pathology: Venous leg ulcer. Interactive budget impact model with Excel®
- Pharmaceuticals: Interactive cost-utility Markov model with Excel®, pathology: Severe aortic stenosis (SAS).
- Pharmaceuticals: Bayesian multi-treatment meta-analysis with Winbugs/R, pathology: Severe aortic stenosis (SAS).
Pharmaceuticals: Bayesian multi-treatment meta-analysis, interactive cost-utility Markov model with Excel®, pathology: Severe aortic stenosis (SAS).
University Hospital Center: Medico-economic evaluation in real life of an innovative organization with R and Excel®, pathology: Diabetes (Erasmus Health Insurance data, CHU data).
University Hospital Center: Medico-economic model of an antiseptic solution for the prevention of catheter infections in intensive care units, with R and Excel®.
Pharmaceuticals: Markov cost-utility model under Excel®, pathology: Severe asthma.
Pharmaceuticals: Excel® budget impact interactive model, pathology: Severe asthma.
Pharmaceuticals: Markov cost-utility model under Excel®, pathology: Chronic Hepatitis C.
University Hospital Center: Pathology cost study in Excel®, pathology: COPD. Cost-effective Markov model under R and Excel®, pathology: COPD. Excel® budget impact model, pathology: COPD
Pharmaceuticals: Cost-utility Markov model under Excel®, pathology: Chronic Hepatitis C. Excel® interactive budget impact model, pathology: Chronic Hepatitis C.
Pharmaceuticals: Cost-effective prospective evaluation of a therapeutic innovation in the prevention of catheter infection in intensive care unit: Markov model not homogeneous on several catheters and several infections, under Excel®.
Pharmaceuticals: Realization of a budgetary impact model with user interface of the progressive diffusion of a therapeutic innovation in the treatment of actinic keratosis: Markov model on dynamic cohort under Excel®.
Pharmaceuticals: Cost-effectiveness evaluation of a therapeutic innovation in the treatment of actinic keratosis: Excel® decision tree model.
Pharmaceuticals: Realization of a multi-treatment meta-analysis (under Winbugs and R) evaluating the comparative effectiveness of a therapeutic innovation in the treatment of actinic keratosis.
Pharmaceuticals: Statistical analysis of a database on psoriasis. Study of compliance with prescriptions, comorbidities, quality of life and economic aspects.
Pharmaceuticals: Excel® interactive budget impact model of the progressive diffusion of a therapeutic innovation in the management of venous leg ulcers.
Cost-effectiveness Markov model with Excel®
French Ministry of Health:
Developing a disease model compensation for one pathology from an international study.
Regional Health Insurance in Midi-Pyrénées:
External assessment of the regional health network DIAMIP, in diabetes melitus. Study funded by the Fund Intervention for Quality and Coordination Care (FIQCS Midi-Pyrénées).
Participation in research for SFDRMG
(French Society for Documentation and Research for General Practice):
Assessing the impact of the use of reminders
IT for improving health Professional practice (URIAP study).
Regional Health Insurance in Ile-de-France: Assessing the satisfaction of health professionals awareness by the model of private practice grouped in two cities in the Ile-de-France.
ARIANE 72 RSP network, a network of palliative care in Sarthe:
Survey of quality of life and satisfaction caregivers (relatives, family friends) in the under management by the network. A satisfaction survey of concerned physicians was also planned. A survey of key network partners (hospitals, institutions, etc.) was also performed and this study aimed to assess the particular positioning system 72 in its Ariane professional environment (medical, medico-Social and institutional). This study was funded by Regional Health Insurance in Pays de la Loire.
Regional Health Insurance in Auvergne:
External evaluation of three health Diabetes networks funded by Intervention Fund for Quality and Care Coordination.
Fravimed:
Performing a mathematical model of budgetary impact (public hospital perspective) for an innovative device in Neurosurgery (Markovian decision Process).
Diabetes Network in Trégor:
External assessment of the Health Network in
diabetes melitus.
Diabetes Network in Normandie:
Qualitative impact assessment of the health network, satisfaction of patients, health professionals and partners network (associations, other networks,
hospitals, etc.).
Grouping Redeployment Project Implementation (RIR Association Ile de France):
Assessment of the efficiency of the proposed association RIR-IDF, which received financial support from the Fund Aid for Quality Care City (Ile-De-France), to conduct feasibility studies and implementation of consolidation exercises of various health professionals.
Ministry of Health:
Medico-economic study of the care pathway of patients with hepatitis C, excluding complication of cirrhosis and cancer.
PRIORY network, local network for continued care at home: Medico-economic external assessment of PRIORY.
The network
PRIORY provides the patient with a severe or progressive disease, a situation
dependency or disability, the possibility of staying at home if the desire is expressed. It offers comprehensive and interdisciplinary and coherent care around the general practitioner.
